RESEARCH PAPERS:

1. GUEST EDITOR OF HOT TOPIC ISSUE "CURRENT STRATEGIES IN TARGETING BRAIN DISORDERS- A THEMATIC ISSUE" CNS & Neurological Disorders-Drug Targets, 2014, 13, 41-96.

Our first review focuses on important aspects of programmed necrosis (necroptosis) which contributes to the pathogenesis of various diseases (, including ischemic stroke, traumatic brain injury, neurodegenerative disorders and brain tumor. The second review highlights the role of glial cells in G- protein signaling which contributes to brain disorders. The third review points out new unconventional targets being explored for treatment of neuropathic pain. Fourth review describes the neuromodulatory and neuroprotective effects of herb Dr. Rajanikant G. K. Necroptosis: Who Knew There Were So Many Interesting Ways to Die)Dr. Seyeon Park: Recent approaches for studying the role of glia)Dr. P. Yogeeswari: Future Directions in the Treatment of Neuropathic Pain: A Review on Various Therapeutic Targets).Selaginella Delicatula in chemical models of neurodegenerative diseases (Dr. Muralidhara: Insights on the neuromodulatory propensity of Selaginella (Sanjeevani) and its potential pharmacological applications). The fifth and last review explains neurodegeneration and adult neurogenesis regulation by MicroRNAs (miRNAs) (Dr. Sanjay Yadav: Regulatory triangle of neurodegeneration, adult neurogenesis and microRNAs)

2. B.V.S.S. SUNIL KUMAR,D. SRIRAM, P. YOGEESWARI,  - GUEST EDITORS OF "RECENT TRENDS IN LIBRARY DESIGN AND VIRTUAL SCREENING IN MEDICINAL CHEMISTRY AND DRUG DISCOVERY"   CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014,14, No. 17

_____________________________________________________________________________________

    2019

1. S. Dwivedi, R. Medishetti, R. Rani, A. Sevilmedu, P. Kulkarni,P. Yogeeswari, Larval zebrafish model for studying the effects of valproic acid on neurodevelopment . An approach towards modeling autism. J. Pharmacol. Toxicol. Methods, 2019, 95, 56-65.

 2018

1. G. Surineni, S.K. Marvadi,P. Yogeeswari, D. Sriram, S. Kantevari, Dibenzofuran, dibenzothiophene and N-methyl carbazole tethered 2-aminothiazoles and their cinnamides as potent inhibitors ofMycobacterium tuberculosis. Bioorg. Med. Chem. Lett., 2018, 28, 1610-1614.
2. S.P. Kasturi, S. Surarapu, S. Uppalanchi, S. Dwivedi, P. Yogeeswari, D.K. Sigalapalli, N.B. Bathini, K.S. Ethiraj, J.S. Anireddy, Synthesis, molecular modeling and evaluation of aplha-glucosidase inhibition activity of 3,4-dihydroxy piperidines.Eur. J. Med. Chem., 2018, 150, 39-52.
   
   
3. V. Nalla, A. Shaikh, S. Bapat, R. Vyas, M. Karthikeyan, P. Yogeeswari, D. Sriram, M. Muthukrishnan, Identification of potent chromone embedded [1,2,3]-triazoles as novel anti-tubercular agents.Royal Society Open Sci., 2018, 5, Article no. 171750. 

4. F.K. Mediesse, T. Boudjeko, A. Hasitha, M. Gangadhar, W.F. Mbacham, P. Yogeeswari, Inhibition of lipopolysaccharide (LPS)-induced neuroinflammatory response by polysaccharide fractions of Khaya grandifoliola (C.D.C.) stem bark, Cryptolepis sanguinolenta (Lindl.) Schltr and Cymbopogon citratus Stapf leaves in raw 264.7 macrophages and U87 glioblastoma cells,BMC Complimentary and Alternative Medicine, 2018, 18, Article no. 86.

5. S. Kasturi, S. Surarapu, S. Uppalanchi, H.S. Anantaraju, S. Dwivedi, P. Yogeeswari, K.S. Ethiraj, J.S. Anireddy, Synthesis of new heteroaryl substituted morpholine tagged triazines and evaluation of their cytotoxic activity,Lett. Drug Des. Discov., 2018,15. 181-192.

_____________________________________________________________________________________________ 

 2017

1. G.L. Goud, S. Ramesh, A. Dongamanti, V. P. Reddy,  D. Sriram,P. Yogeeswari, S. Balabadra, V. Manga, Design, synthesis, molecular docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones.MedChemComm., 2017, Published first online in Jan 2017.
   
   
2. P. Kulkarni, S. Yellanki, R. Medishetti, D. Sriram, U. Saxena,  Yogeeswari,Novel zebrafish EAE model: A quickin vivo screen for multiple sclerosis. Mult. Scler. Relat. Disord, 2017, 11, 32-39.
   
   
3. H.H. Abdu-Alah,  B.G. Youssif, M.H. Abdelrahman, M.K. Abdel-Hamid, R.S. Reshma,  P. Yogeeswari, T. Aboul-Fadl, D. Sriram, D, Synthesis and antimycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicyl hydrazones: Revitalizing an old drug. Arch. Pharm. Res., 2017, 40, 168-179.
   
   
4. S. Kasturi, S. Surarapu, S. Uppalanchi, J.S. Anireddy, S. Dwivedi, H.S. Anantaraju,  P. Yogeeswari, D.K. Sigalapalli, Synthesis and alpha-glucosidase inhibition activity of dihydroxy pyrrolidines. Bioor. Med. Chem. Lett., 2017, In Press.
   
   
5. 5. B. Kummari, N. Polkam, P. Ramesh, H.S. Anantaraju,   Yogeeswari, J.S. Anireddy, S.D. Guggilapu, B.N. Babu,  Design and synthesis of 1,2,3-triazole-etodolac hybrids as potent anticancer molecules. RSC Adv., 2017, 7, 23680-6.

 2016

1. P. Suryadevara, P. Yogeeswari, V. Soni, P.B. Devi, V.K. Nandicoori, D. Sriram, Computational sampling and simulation based assessment of novel Mycobacterium tuberculosisglutamine synthetase inhibitors: Study involving structure based drug design and free energy pertubation. Curr. Topics in Med. Chem., 2016, 16, 978-995.
   
   
2.  J. Ramprasad, N. Nayak, U. Dalimba,P. Yogeeswari, D. Sriram, Ionic liquid promoted one-pot synthesis of thiazole-imidazo[2,1-b][1,3,4] thiadiazole hybrids and their antitubercular activity.Med. Chem. Commun. 2016, 7, 338-344.
   
   
3.  D.S. Agarwal, H.S. Anantaraju,P. Yogeeswari, D. Sriram, S.H. Nanjegowda, P. Mallu, R. Sakhuja, Synthesis, characterization and biological evaluation of bile acid-aromatic/heteroaromatic amides linkedvia amino acids as anticancer agents. Steroids 2016, 107, 87-97. 
   
   
4.  N. Panathur, N. Gokhale, U. Dalimba, P.V. Koushik, P. Yogeeswari, D. Sriram, Synthesis of novel 5-[(1,2,3-triazol-4-yl)methyl-3H-pyridazino[4,5-b]indol-4-one derivatives by click reaction and exploration of their anticancer activity.Med. Chem. Res. 2016, 25, 135-145. 
   
   
5.  F. Rouatbi, M. Askri, F. Nana, G. Kirsch, D. Sriram, P. Yogeeswari, Synthesis of new spirooxindole derivatives through 1,3-dipolar cycloaddition of cyclomethine ylides and their antitubercular activity.Tetrahed. Lett., 2016,57, 163-167.
   
   
6.  B. Medapi, N. Meda, P. Kulkarni,wari, D. Sriram, Development of acridine derivatives as selectiveMycobacterium tuberculosis DNA gyrase inhibitors. Bioorg. Med. Chem., 2016, 24, 877-885.
   
   
7. Yogeeswari, Energy-based pharmacophore and 3D QSAR modeling combined with virtual screening to identify novel small molecule inhibitors of SIRT1.J. Chem. Inf. Model., 2016, 56, 173-187.
   V.K. Pulla, D.S. Sriram, S. Viswanadha, D. Sriram,  P. Yogees

8. N. Nayak, J. Ramprasad, U. Dalimba, Yogeeswari, D. Sriram, Synthesis and antimycobacterial screening of new N-(4-(5-aryl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl)phenyl)-4-amide derivatives. Chinese Chem. Lett., 2016, In press.
   
   
9.  V.U. Jeankumar, S. Saxena, R. Vats, R.S. Reshma, R. Janupally, P. Kulkarni, P. Yogeeswari, D. Sriram, Structure-guided discovery of antitubercular agents that target the gyrase ATPase domain. Chem. Med. Chem., 2016, 11, 539-548.

10. , D. Sriram, Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives asMycobacterium tuberculsosis pantothenate synthase inhibitors. Bioorg. Med. Chem., 2016, 24, 1298-1307.
    G. Samala, P.B. Devi, S. Saxena, N. Meda,  Yogeeswari

______________________________________________________________________________________________

11. P.B. Devi, J.P. Sridevi, S. Saxena, M. Chandran, R.R. Srilakshmi, R. Yadav, P. Yogeeswari, D. Sriram, Design and development of Mycobacterium tuberculosis lysine aminotransferase inhibitors for latent tuberculosis infection. Chem. Biol. Drug Design, 2016, 87, 265-274.
    
    
12. K. Brunner, S. Maric, R.S. Reshma, H. Almquist, B. Seashore-Ludlow, A.L. Gustavsson, O. Poyraz,  P. Yogeeswari, T. Lundback, M. Vallin, D. Sriram, R. Schnell, G. Schneider, Inhibitors of cysteine synthase CysM with antibacterial potency against dormantMycobacterium tuberculosis. J. Med. Chem., 2016, 59, 6848-6859.
    
    
13.  V.U. Jeankumar, R.S. Reshma, R. Vats, R. Janupally, S. Saxena, P. Yogeeswari, D. Sriram, Engineering another class of antitubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. Eur. J. Med. Chem., 2016, 122, 216-231.
    
    
14. G. Surineni,  P. Yogeeswari, D. Sriram, S. Kantevari, Click-based synthesis and antitubercular evaluation of dibenzofuram tethered thiazolyl11,2,3-triazolyl acetamides. Bioorg. Med. Chem. Lett., 2016, 26, 3684-3689.
    
    
15. L. Pulipati, J.P. Sridevi, P. Yogeeswari, D. Sriram, S. Kantevari, Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides. Bioorg. Med. Chem. Lett., 2016, 26, 3135-3140.
    
    
16. S.K. Banerjee, M. Kumar, R. Alokam, A.K. Sharma, A. Chatterjee, R. Kumar, S.K. Sahu, K. Jana, R. Singh, P. Yogeeswari, D. Sriram, J. Basu, M. Kundu, Targeting multiple response regulators of Mycobacterium tuberculosis augments the host immune response to infection. Sci, Rep., 2016, 6, 25851.
    
    
17. L. Pulipati, P. Yogeeswari, D. Sriram, S. Kantevari, Click-based synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages. Bioorg. Med. Chem. Lett., 2016, 26, 2649-2654.
    
    
18. P.S. Jadhavar, T.M. Dhameliya, M.D. Vaja, D. Kumar, J.P. Sridevi, P. Yogeeswari, D. Sriram, A.K. Chakraborti, Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as antitubercular agents. Bioorg. Med. Chem. Lett., 2016, 26, 2663-2669.
    
    
19. E. Tatar, S. Karakus, S.G. Kucukguzel, S. Oktem Okullu, N. Unubol, T. Kocagoz, E. De Clercq, G. Andrei, R. Snoeck, C. Pannecouque, S. Kalayci, F. Sahin, D. Sriram, P. Yogeeswari, I. Kucukguzel, Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as antitubercular agents. Biol. Pharm. Bull., 2016, 39, 502-515.
    
    
20. K.A. Bobesh, J. Renuka, R.R. Srilakshmi, S. Yellanki, P. Kulkarni, P. Yogeeswari, D. Sriram, Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? Mycobacterium tuberculosis novel bacterial topoisomerase inhibitors. Bioorg. Med. Chem., 2016, 24, 42-52.
    
    
21. H.S. Anataraju, M.B. Battu, S. Viswanadha, D. Sriram, P. Yogeeswari, Cathepsin D inhibitors as potential therapeutic option for breast cancer treatment: Drug design and bioevaluation against triple negative and triple positive breast cancer. Mol Diversity, 2016, 20, 521-535.
    
    
22. N. Nayak, J. Ramprasad, U. Dalimba,P. Yogeeswari, D. Sriram, H.S.S. Kumar, S.K. Peethambar, R. Achur, Synthesis of new pyrazole-triazole hybrids by click reaction using a green solvent and evaluation of their antitubercular and antibacterial activity. Res. Cheml. Intermed, 2016, 42, 3721-3741.
    
    
23. M. Akula,P. Yogeeswari, D. Sriram, M. Jha, A. Bhattacharya, Synthesis and antitubercular  activity of fused thieno-/furo-quinoline compounds. RSC Advances, 2016, 6, 46073-46080.
    
    
24. R.S. Reshma, S. Saxena, K.A. Bobesh, V.U. Jeankumar, S. Gunda, P. Yogeeswari, D. Sriram, Design and development of new class ofMycobacterium tuberculosisAlanine dehydrogenease inhibitors. Bioorg. Med. Chem., 2016, 24, 4499-4508.
    
    
25. R.S. Reshma,P. Yogeeswari, D. Sriram, Design and development of novel inhibitors for the treatment of latent tuberculosis. Int. J. Mycobacteriol., 2016, In Press.
    
    
26. B. Tanwar, A. Kumar,P. Yogeeswari, D. Sriram, A.K. Chakraborti, Design, Development of new synthetic methodology, and biological evaluation of substituted quinolines as new antitubercular leads. Bioorg. Med. Chem. Lett., 2016, 26, 5960-5966.
    
    
27. G. Samala, P.B. Devi, S. Saxena, S. Gunda,P. Yogeeswari, D. Sriram, Antitubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thien0[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicativeMycobacterium tuberculosis. Bioorg. Med. Chem., 2016, 24, 5556-5564.
    
    
28. B. Eroglu, K. Ozadali-Sari, O. Unsal-Tan, S. Dharmarajan,  P. Yogeeswari, A. Balkan, Novel Thiazolidinone-Azole Hybrids: Design , Synthesis and Antimycobacterial studies. Iran J. Pharm. Res., 2016, 15, 783-790.

________________________________________________________________________________________________

   2015

1. G. Jose, T.H.S. Kumara, G. Nagendrappa, H.B.V. Sowmya, D. Sriram, P. Yogeeswari, J.P. Sridevi, T.N.G. Row, A.A. Hosamani, P.S.S. Ganapathy, N. Chandrika, L.V. Narendra, Synthesis, molecular docking and antimycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives, Eur. J. Med. Chem. 2015, 89, 616-627.  
                
2. V.U. Jeankumar, S. Priyanka, J. Renuka, J.P. Sridevi, P. Kulkarni, P. Yogeeswari,  D. Sriram, Exploring the Gyrase ATPase domain for tailoring newer anti-tubercular drugs: Hit to lead optimization of a novel class of thiazole inhibitors, Bioorg. Med. Chem. 2015, 23, 588-601.
   
   
3. V.U. Jeankumar, J. Renuka, S. Saxena, J.P. Sridevi, L. Reshma, M. Brahmam, P. Kulkarni, P. Yogeeswari,  D. Sriram, Enabling the (3+2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of Gyrase ATPase domain:  Lead optimization and structure activity profiling, Org. Biomol. Chem. 2015, 13, 2423-2431.
   
   
4.  4. G. Surineni, P. Yogeeswari,  D. Sriram, S. Kantevari, Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis, Bioorg. Med. Chem. Lett. 2015, 25, 485-491.
   
   
5. 5. K.M. Naidu, H.N. Nagesh, M. Singh, D. Sriram, P. Yogeeswari, K.V.G. Chandrasekar,  Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors, Eur. J. Med. Chem. 2015, 92, 415-426.
   
   
6. J. Renuka, V.U. JeanKumar, M. Brahmam, P.B. Devi, P. Suryadevaraya, P. Kulkarni,P. Yogeeswari,  D. Sriram, Design and biological evaluation of furan/pyrrole/thiophene-2-carboxamide derivatives as efficient DNA gyraseB inhibitors of Staphylococcus aureus, Chem. Biol. Drug Des. 2015, 86, 918-925.
   
   
7. P. Purkayastha, A. Malapati,P. Yogeeswari, D. Sriram, A review on GABA/Glutamate pathway for therapeutic intervention of ASD and ADHD, Curr. Med. Chem. 2015 22, 1850-1859.
   
   
8. R. Raut, H. Beesetti, P. Tyagi, I. Khanna, S.K. Jain, V.U. Jeankumar, P. Yogeeswari, D. Sriram, S. Swaminathan, A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.Virol. J. 2015, 12, 16/1-16/7.
   
   
9. S. Saxena, G. Samala, J.P. Sridevi, P.B. Devi, P. Yogeeswari, D. Sriram, Design and development of novel Mycobacterium tuberculosis- alanine dehydrogenase inhibitors. Eur. J. Med. Chem. 2015, 92, 401-414. 
   
   
10. M. Brahmam, R. Janupally, S. Saxena, J.P. Sridevi, M. Raghavender, P. Kulkarni, P. Yogeeswari, D. Sriram, Design and synthesis of novel  quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosisDNA gyrase B inhibitors. Bioorg. Med. Chem. 2015, 23, 2062-2078.
    
    
11. J.M. Gajbhiye, N.A. More, M.D. Patil, R. Ummanni, S.S. Kotapalli, P. Yogeeswari, D. Sriram, Discovery of Rimonabant  and its potential analogues as anti-TB drug candidates. Med. Chem. Res. 2015, 24, 2960-2971.
    
    
12. S. Saxena, G. Samala, R. Janupally, J.P. Sridevi, P. Yogeeswari, D. Sriram, Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA Gyr B domain. Bioorg. Med. Chem. 2015, 23, 1402-1412.
    
    
13. P.B. Devi, S. Jogula, P.A. Reddy, S. Saxena, J.P. Sridevi, D. Sriram, P. Yogeeswari, Design of novel Mycobacterium tuberculosispantothenate synthetase inhibitors: Virtual screening, synthesis and in-vitro biological activities. Mol Informatics 2015, 34, 147-159.
    
    
14. V.K. Pulla, D.S. Sriram, V. Soni, S. Viswanadha, D. Sriram, P. Yogeeswari, Targeting NAMPT for therapeutic intervention of cancer and inflammation: Structure-based drug design and biological screening.Chem. Biol. Drug Design 2015, 86, 881-894.
    
    
15. P. Purkayastha, R. Alokam, A. Malapti, D. Sriram, P. Yogeeswari, Structural models for the design of PKMzeta inhibitors with neurobiological indications.Mol. Informatics 2015,34, 665-678.
    
    
16. M. Chandran, J. Renuka, J.P. Sridevi, G.S. Pedgaonkar, V. Asmitha, P. Yogeeswari, D. Sriram, Benzothiazinone-piperazine derivatives as efficientMycobacterium tuberculosisDNA Gyrase inhibitors. Int. J. Mycobacteriol. 2015, 4, 104-115.
    
    
17. J.P. Sridevi, P. Suryadevara, R. Janupally, V. Soni, S. Jogula, V. Soni, H.S. Anataraju, P. Yogeeswari, D. Sriram, Identification of potential Mycobacterium tuberculosistopoisomerase I inhibitors: A study against active, dormant and resistant tuberculosis.Eur. J. Pharm Sci. 2015, 72, 81-92.
    
    
18. S.S. Dinavahi, P. Yogeeswari, D. Sriram, S. Viswanadha, A novel potent, small molecule AKT inhibitor exhibits efficacy against lung cancer cells in vitro. Cancer Res. Treatment. 2015,Pub date (electronic): Jan 2, 2015; doi: http://dx.doi.orf/10.4143/crt2014.057.
    
    
19. J. Ramprasad, N. Nayak, U. Dalimba,P. Yogeeswari, D. Sriram, S.K. Peethambar, R. Achur, H.S.S. Kumar, Synthesis and biological evaluation of new imidazo[2.1-b][1,3,4]thiadiazole-benzimidazole derivatives.Eur. J. Med. Chem. 2015, 95, 49-63.
    
    
20. P. Purkyastha, A. Rallapalli, N.L. Bhanu Murthy, A. Malapati, P. Yogeeswari, D. Sriram, Effect of feature selection on kinase classification models.SpringerBriefs in Applied Sciences & Technology, 2015,6, 81-86.
    
    
21. P. Suman, C. Dayakar, K. Rajkumar, B. Yashwanth, P. Yogeeswari, D. Sriram, J.V. Rao, B. China Raju, Synthesis and antimycobacterial activity of 2-chloronicotinaldehydes based novel 1H-1,2,3-triazolylbenzohydrazides. Bioorg. Med. Chem. Lett., 2015,25, 2390-2394
    
    
22.  V. Soni, P. Suryadevaraya, D. Sriram, OSDD Consortium, V.K. Nandicoori, P. Yogeeswari, Structure-based design of diverse inhibitors of mycobacterial N-acetylglucosamine-1-phosphate uridyltransferase: Combined molecular docking and dynamic simulation with bioevaluation.J. Mol. Model., 2015,21, 1-12.
    
    
23.  G.O. Petersen, S. Saxena, J. Renuka, V. Soni, P. Yogeeswari, D.S. Santos, C.V. Bizarro, D. Sriram, Structure-based virtual screening as a tool for the identification of novel inhibitors againstMycobacterium tuberculosis3-dehydroquinate dehratase. J. Mol. Graph. Model. 2015, 60, 124-131.
    
    
24.  N. Panathur, N. Gokhale, U. Dalimba, P.V. Koushik, P. Yogeeswari, D. Sriram, New indole-isooxazolone derivatives: Synthesis, characterization andin vitroSIRT1 inhibition studies. Bioorg. Med. Chem. Lett., 2015, 25, 2768-2772.

25. M. Brahmam, J. Renuka,J.P. Sridevi, S. Priyanka, P. Yogeeswari, D. Sriram, 4-Aminoquinoline derivatives as novelMycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation. Eur. J. Med. Chem., 2015, 103, 1-16. 

26. P.B. Devi, J.P. Sridevi, S.S. Kakan, S. Saxena, V.U. Jeankumar, H.S. Anantaraju, R.R. Srilakshmi,  P. Yogeeswari, D. Sriram, Discovery of novel lysine aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.Tuberculosis,2015, 95, 786-794.

27.  Y. Nkizinkiko, B.V.S.S. Kumar, V.U. Jeankumar, T. Haikarainen, J.Koivunen, C. Madhuri, P. Yogeeswari, H. Venkannagari, E. Obaji, T. Pihlajaniemi, D. Sriram, L. Lehtio, Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics.Bioorg. Med. Chem., 2015, 23, 4139-4149. 

28. K. Pissinate, D.C. Rostirolla, L.M. Pinheiro, P. Suryadevara, P. Yogeeswari, D. Sriram, L.A. Basso, P. Machado, D.S. Santos, Synthesis and evaluation of thiazolyl-1H-benzo[d]imidazole inhibitors ofMycobacterium tuberculosisinosine monophosphate dehydrogenase. J. Brazillian Soc., 2015, 26.

29.  A. Mallika, P.V. Koushik, M.B. Battu, V.U., Jeankumar, R. Alvala, H.S. Anantaraju, P. Yogeeswari, D. Sriram, Novel SIRT-1 inhibitors-mediated apoptosis in prostate cancer: In-vitro and in-vivo evaluation.Life Sci., 2015, In Press. 

30. C. Mhiri, S. Boudriga, M. Askri, M. Knorr, D. Sriram, P. Yogeeswari, F. Nana, C. Golz, C. Strohmann, Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.Bioorg. Med. Chem. Lett., 2015, 25, 4308-4313.

31. A. Kamal, B.V.S. Reddy, B. Sridevi, A. Ravikumar, A. Venkateswarlu, G. Sravanthi, J.P. Sridevi,P. Yogeeswari, D. Sriram, Synthesis and biological evaluation of phaitanthrin congeners as antimycobacterial agents. Bioorg. Med. Chem. Lett., 2015, 25, 3867-3872.

32.  F.D.T. Bomba, B.A. Wandji, B.N. Piegang, M.D. Awouafack, D. Sriram, P. Yogeeswari, A. Kamanyi, T.B. Nguelefack, Antinociceptive properties of the aqueous and methanol extracts of the stem bark ofPtersianthus macrocarpus(p. Beauv) Liben (lecythidaceae) in mice. J. Ethnopharmacol., 2015, 174, 66-73.

33. R. Trivedi, R.R. Eda, S.V.S. Akella, S. Balasubramanian, H.S. Anantaraju, D. Sriram,P. Yogeeswari, N. Nagesh, Sugar-boronate ester scaffold tethered pyridyl-imine palladium (II) complexes: Synthesis and their anticancer evaluation.Dalton Transactions, 2015, Published online on 1 Sept 2015, DOI: 10.1039/C5DT03266K

34.  J. Ramprasad, N. Nayak, U. Dalimba,P. Yogeeswari, D. Sriram, One-pot synthesis of new triazole-imidazo[2,1-b][1,3,4] thiadiazole hybridsvia click chemistry and evaluation of their antitubercular activity. Bioorg. Med. Chem. Lett., 2015, 25, 4169-4173.

35.  G. Surineni, P. Yogeeswari, D. Sriram, S. Kantevari, Rational design, synthesis and evaluation of novel substituted 1,2,3-triazolylmethyl carbazoles as potent inhibitors of Mycobacteriumtuberculosis. Med. Chem. Res. 2015, 24, 1298-1309.

36. N. Nayak, J. Ramprasad, U. Dalimba, P. Yogeeswari, D. Sriram, H.S.S. Kumar, S.K. Peethambar, R. Achur, Synthesis of new pyrazole-triazole hybrids by click reaction using a green solvent and evaluation of their antitubercular and antibacterial activity.Res. Chemical Intermediates (Springer) 2015,Online since 8th September 2015, In press.

37.  A. Reshma, S. Singhal, G. Srivasthav, S. Garigipati, S. Puppala, D. Sriram, P. Yogeeswari, Design of dual inhibitors of ROCK-I and NOX-2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including autism spectrum disorder, Mol. BioSyst. 2015,11, 607-617.

38. N. Panathur, N. Gokhale, U. Dalimba, P.V. Koushik, P. Yogeeswari, D. Sriram, Synthesis of novel 5-[(1,2,3-triazol-4-yl)methyl]-1-methyl-3H-pyridazino[4,5-b]indol-4-one derivatives by click reaction and exploration of their anticancer activity.Me. Chem. Res. 2015, 1-14.

39. E.R. Reddy, R. Trivedi, A.V. Sarma, B. Sridhar, H.S. Anatarajau, D. Sriram, P. Yogeeswari,N. Nagesh, Sugar-boronate ester scaffold tethered pyridyl-imine palladium(ii) complexes: Synthesis and their in-vitro anticancer evaluation.Dalton Trans. 2015, 44, 17600-17616.

40. V. Soni, S. Upadhayay, P. Suryadevara, G. Samala, A. Singh, P. Yogeeswari, D. Sriram, V.K. Nandicoori, Depletion ofM. tuberculosisGlmU from infected murine lungs effects the clearance of the pathogen. PLoS Pathogen, 2015, 11, e1005235.

41.  K.A. Bobesh, J. Renuka, R.R. Srilakshmi, S. Yellanki, P. Kulkarni, P. Yogeeswari, D. Sriram, Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? :Mycobacterium tuberculosisnovel bacterial topoisomerase inhibitors. Bioor. Med. Chem., 2015, In Press.

42. F. Rouatbi, M. Askri, F. Nana, G. Kirsch, D. Sriram, P. Yogeeswari, Synthesis of new spirooxindole derivatives through 1,3-dipolar cycloaddition of azomethine ylides and their antitubercular activity.Tetrahedrom Lett., 2015, In Press.

43.  M. Mujahid, P. Yogeeswari, D. Sriram, U.M.V. Basavanag, E. Diaz-Cervantes, L. Cordoba-Bahena, J. Robles, R.G. Gonnade, M. Karthikeyan, R. Vyas, M. Muthukrishnan, Spirochromene-chalcone conjugates as antitubercular agents: Synthesis, bioevaluation and molecular modeling studies.RSC Advances, 2015, 5, 106448.

2014

1.     S. Saxena, P. Brindha Devi, V. Soni, P. Yogeeswari, D. Sriram, Identification of novel inhibitors against Mycobacterium tuberculosisL-Alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening, J. Mol. Graphics Modelling 2014, 47, 37-43. 
2. D. Addla, A. Jallapally, D. Gurram, P. Yogeeswari, D. Sriram, S. Kantevari, Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl) phenothiazine-[1,2,3] triazole hybrids, Bioorg. Med. Chem. Lett. 2014, 24, 233-236. 
3. M. Sharma, V. Deekshith, A. Semwal, D. Sriram, P. Yogeeswari, Discovery of tetrahydropyrido[4,3-d]pyrimidine derivatives for the treatment of neuropathic pain. Bioorg. Chem. 2014, 52C, 69-76. 
4. V.U. Jean Kumar, J. Renuka, V.K. Pulla, V. Soni, J.P. Sridevi, P. Suryadevaraya, M. Shravan, R. Medishetti, P. Kulkarni, P. Yogeeswari, D. Sriram, Devdelopment of novel N-linked aminopiperidine based mycobacterial DNA gyrase B inhibitors: Scaffold hopping from known antibacterial agents. Int. J. Antimicrob. Agents, 2014, 43, 269-278.
5. Madhu Babu, A, Madhuri Chandra, D. Sriram, P. Yogeeswari, Pharmacophore-based 3D-QSAR and molecular docking studies to identify new non-peptidic inhibitors of Cathepsin S, Curr. Med. Chem. 2014, 21, 1910-1921.
6. M. Gangadhar, R. Mishra, D. Sriram, P. Yogeeswari, Future directions in the treatment of neuropathic pain: A review on various therapeutic targets. CNS Neurol. Disord. Drug Targets, 2014, 13, 63-81.
7. V.U. Jean Kumar, A. Reshma, P. Sridevi, S. Priyanka, S. Sai, S. Peddi, S. Sahithi, A. Mallika, P. Yogeeswari, D. Sriram, Discovery and structure optimization of a series of isatin derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors. Chem. Biol. Drug Design, 2014, 83, 498-506.
8. J.T. Patrisha, D. Manvar, S. Kondepudi, M.B. Battu, D. Sriram, A. Basu, P. Yogeeswari, N.K. Basu, Multiple e-pharmacophore modeling, 3D-QSAR, and High-throughput virtual screening of Hepatitis C Virus NS5B polymerase Inhibitors. J. Chem. Inf. Model. (ACS), 2014, 54, 539-552.
9. H.N. Nagesh, N. Suresh, M.K. Naidu, B. Arun, P.J. Sridevi, D. Sriram, P. Yogeeswari, K.V.G. Chandrasekhar, Synthesis and evaluation of antitubercular activity of 6-(4-substituted piperazin-1-yl)phenanthridine analogous. Eur. J. Med. Chem. 2014, 74C, 333-339.
10. T. Yempala, J.P. Sridevi, P. Yogeeswari,D. Sriram, S. Kantevari, Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis. Eur. J. Med. Chem. 2014, 71, 160-167.
11. N. Radhika, G. Samala, J.P. Sridevi, P. Yogeeswari, D. Sriram, Development of antimycobacterial tetrahydrothieno[2.3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead. Eur. J. Med. Chem. 2014, 76, 110-117.
12. S. Ganesh, P.B. Devi, R. Nallangi, J.P. Sridevi, P. Yogeeswari, D. Sriram, Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosispatothenate synthetase inhibitors: Molecular hybridization from known antimycobacterial leads. Bioorg. Med. Chem. 2014, 22, 1938-1947.
13. R. Alokam, V.U. Jean Kumar, J. Padma Sridevi, S.S. Matikonda, S. Peddi, M. Alvala, P. Yogeeswari, D. Sriram, Identification and Structure-Activity Relationship study of Carvacrol derivatives as Mycobacterium tuberculosis, Chorismate mutase inhibitors,J. Enzyme Inhibition Med. Chem., 2014, 29, 547-554.
14. K. Ozadali, O.T. Unsal, P. Yogeeswari, D. Sriram, A. Balkan, Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives. Bioorg. Med. Chem. Lett., 2014, 24, 1695-1697.
15. M. Akula, J.P. Sridevi, P. Yogeeswari,D. Sriram, A. Bhattacharya, New class of antitubercular compounds: Synthesis and antitubercular activity of 4-substituted pyrrolo[2,3-c]quinolines. Monatshefte fur Chemie-Chemical monthly, 2014, 145, 811-819.
16. S.S. Dinavahi, S. Nyayapathy, P. Yogeeswari, D. Sriram, S. Viswanadha, Combined inhibition of PDE4 and PI3Kdelta modulates the inflammatory component involved in the progression of chronic obstructive pulmonary disease. Drug Res. 2014, 64, 214-219.
17. S. Ganesh, S.S. Kakan, N. Radhika, P.B. Devi, J.P. Sridevi, S. Saxena, P. Yogeeswari, D. Sriram, Investigating structure-activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4- (4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione. Int. J. Mycobactriol. 2014, 3, 117-126. 
18. P. Venkat Koushik, A. Mallika, S.S. Dinavahi, S. Viswanadha, D. Sriram, P. Yogeeswari, Structure-based drug design of small molecule SIRT-1 modulaters to treat cancer and metabolic disorders. J. Mol. Graphics Modelling 2014, 52, 46-56.
19. S.B. Kumar, M. Ravinder, G. Kishore, V.J. Rao, P. Yogeeswari, D. Sriram, Synthesis, antitubercular and anticancer activity of new Baylis-Hillman adduct-derived N-cinnamyl substituted isatin derivatives. Med. Chem. Res., 2014, 23, 1934-1940.
20. D. Addla, A. Jallapally, D. Gurram, P. Yogeeswari, D. Sriram, S. Kantevari, Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 2014, 24, 1974-1979.
21. H.N. Nagesh, K.M. Naidu, D.H. Rao, J. P. Sridevi, D. Sriram, P. Yogeeswari,K.V.G. Chandrasekhar, Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents. Bioorg. Med. Chem. Lett. 2014, 24, 6805-6810.
22. S. Ganesh, C. Madhuri, J.P. Sridevi, R. Nallangi, P. Yogeeswari, D. Sriram, Synthesis and antitubercular evaluation of 2-iminothiazolidine-4-ones. Eur. J. Chem. 2014, 5, 550-556.
23. P.B. Devi, S. Ganesh, J.P. Sridevi, S. Saxena, A. Mallika, E.G. Salina, D. Sriram, P. Yogeeswari, Structure-guided design of novel thiazolidine derivatives as Mycobacterium tuberculosispantothenate synthatase inhibitors. ChemMedChem. 2014, 9, 2538-2547. 
24. S. Ganesh, N. Radhika, P.B. Devi, S. Saxena, R. Yadav, J.P. Sridevi, P. Yogeeswari, D. Sriram, Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosispantothenate synthetase inhibitors. Bioorg. Med. Chem. 2014, 22, 4223-4232.
25. A.K. Chakraborti, P. Shah, T. Dhameliva, R. Bansal, M. Nautival, D.N. Kommi, P.S. Jadhavar, J.P. Sridevi, P. Yogeeswari, D. Sriram, N-Arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: Design, new methods of synthesis and biological evaluation. Med. Chem. Commum. 2014, 5, 1489-1495.
26. J. Renuka, K.I. Reddy, K. Srihari, V.U. Jeankumar, M. Shravan, J.P. Sridevi, P. Yogeeswari,K.S. Babu, D. Sriram, Design, synthesis and biological evaluation of substituted benzofurans as DNA gyrase B inhibitors of Mycobacterium tuberculosis. Bioorg. Med. Chem. 2014, 17, 4924-4934.   
27. V.U. Jeankumar, J. Renuka, S. Kotagiri, S. Saxena, S.S. Kakan, J.P. Sridevi, S. Yellanki, P. Kulkarni, P. Yogeeswari, D. Sriram, Gyrase ATPase domain as an antitubercular drug discovery platform: Structure-based design and lead optimization of nitothiazolyl carboxamide analogues. ChemMedChem. 2014, 9, 1850-1859.
28. S. Saxena, J. Renuka, V.U. Jeankumar, P. Yogeeswari,D. Sriram, Mycobacterial DNA gyrase B inhibitors: Ligand-based pharmacophore modeling and enzyme inhibition studies. Curr. Topics Med. Chem. 2014, 14, 1990-2005.
29. P.L. Reddy, M.L. Devi, S. Satyanarayana, A. Singh, T.V. Reddy, J.P. Sridevi, G.R. Sekhar, P. Yogeeswari, D. Sriram, U.S.N. Murthy, R. Ummani, B.V.S. Reddy, R. Narender, Design, synthesis and antimycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives. Eur. J. Med. Chem. 2014, 84, 118-126.
30. S. Saxena, J. Renuka, P. Yogeeswari, D. Sriram, Discovery of novel mycobacterial DNA gyrase B inhibitiors: In-silico and in-vitro biological evaluation. Mol. Informatics, 2014,33, 597-609.
31. H.N. Nagesh, A. Suresh, S.D.S.S. Sairam, D. Sriram,P. Yogeeswari, K.V.G. Chandra Sekhar, Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substituted thiazol-4-yl)phenethyl)-4-(3-(4-substituted piperazin-1-yl)alkyl) piperazine hybrid analogues. Eur. J. Med. Chem. 2014, 84, 605-613.
32. K.A. Bobesh, J. Renuka, V.U. JeanKumar, S.K. Shruti, J.P. Sridevi, P. Yogeeswari,D. Sriram, Extending the N-linked aminopiperidine class to the mycobacterial gyrase domain: Pharmacophore mapping from antibacterial leads. Eur. J. Med. Chem. 2014, 89, 593-604.
33. P. Ganesh, J.P. Sridevi, V.U. Jean Kumar, J. Renuka, S. Saxena, P.B. Devi, P. Yogeeswari, D. Sriram, Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors ofMycobacterium tuberculosis InhA. Bioorg. Med. Chem. 2014, 22, 6134-6145.
34. P. Ganesh, J.P. Sridevi, V.U. JeanKumar, S. Saxena, P.B. Devi, J. Renuka, P. Yogeeswari,D. Sriram,                           Development             of  2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatmen tof tuberculosis.  Eur. J. Med. Chem. 2014, 86, 613-627.
35. R.K. Mishra, R. Alokam, S.M. Singhal, G. Srivastav, D. Sriram, N.K. Basu, D. Manvar, P. Yogeeswari, Design of novel Rho kinase inhibitors using energy-based pharmacophore modeling, shape-based screening, in-silico virtual screening and biological evaluation. J. Chem. Inf. Model. 2014, 54, 2876-2886.
36. J. Renuka, V.U. Jeankumar, K.A. Bobesh, V. Soni, P.B. Devi, V.K. Pulla, P. Suryadevara, K.S. Chennubhotla, P. Kulkarni, P. Yogeeswari, D. Sriram, Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyrase B enzyme of Staphylococcus aureus.Bioorg. Med. Chem. 2014, 22, 5970-5987.
37. B.V.S.S. Kumar, D. Sriram, P. Yogeeswari, Recent trends in library design and virtual screening in Medicinal Chemistry and Drug Discovery, Curr. Top. Med. Chem. 2014, 14, 1865. 
38. K.M. Naidu, A. Suresh, J. Subbalakshmi, D. Sriram, P. Yogeeswari, P. Raghavaiah, K.V. Chandrasekhar, Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulphonyl)piperain-1-yl)benzo[d]oxazole derivatives, Eur. J. Med. Chem. 2014, 87C, 71-78.
39. K.I. Reddy, K. Srihari, J. Renuka, K.S. Shree, A. Chuppala, V.U. Jeankumar, J.P. Sridevi, K.S. Babu, P. Yogeeswari, D. Sriram, An efficient synthesis and biological screening of benzofuran and benz[d]isothiazole derivatives for Mycobacterium tuberculosisDNA GyrB inhibition, Bioorg. Med. Chem. 2014, 22, 6552-6563.
40. J.P. Sridevi, H.S. Anataraju, P. Kulkarni, P. Yogeeswari, D. Sriram, Optimization and validation of Mycobacterium marinum induced adult zebra fish model for evaluation of oral antituberculosis drugs,Int. J. Mycobacteriol. 2014, 3, 259-267.
41. B.V. Kumar, D. Sriram, P. Yogeeswari, Medicinal chemistry updates and discovery strategies on potential therapeutic targets. Curr. Top. Med. Chem. 2014, 14, 1939.
42. V. Vijayakumar, K.I. Reddy, A. Chuppala, K.S. Babu, M. Manisha, J.P. Sridevi, P. Yogeeswari, D. Sriram, General and efficient synthesis of benzoxazol-2(3H)-ones: Evolution of its anticancer and antimycobacterial activities. RSC Advances, 2014, 4, 59594-59602. 
43. M. Kratky, E. Novotna, S. Saxena, P. Yogeeswari, D. Sriram, M. Sarvcova, J. Vinsova, Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes. The Scientific World Journal, Volume 2014, Article ID 703053, 6 pages.
44. S. Haddad, S. Boudriga, F. Porzia, A. Soldera, M. Askri, D. Sriram, P. Yogeeswari, M. Knorr, Y. Rousselin, M. Kubicki, Synthesis of novel dispiropyrrolothiazoles by three-component 1,3-dipolar cycloaddition and evaluation of their antimycobacterial activity.  RSC Advances, 2014, 4, 59462-59471.
45. A. Jallapally, D. Addla,P. Yogeeswari, D. Sriram, K. Srinivas, 2-​Butyl-​4-​chloroimidazole based substituted piperazine-​thiosemicarbazone hybrids as potent inhibitors of Mycobacterium tuberculosis, Bioorg. Med. Chem. Lett. 2014, 24, 5520-5524.
46.  K.P. Nagashree, M.M. Kumar, Y.R. Prasad, D. Sriram,P. Yogeeswari, 3D QSAR analysis of 2-                           (substituted aryl) thiazolidine-4-carboxamides as potent antitubercular agents. Curr. Comput.                              Aided Drug Des. 2014, 10, 274-281.
47. S. Saxena, G. Samala, J.P. Sridevi, P.B. Devi, P. Yogeeswari, D. Sriram, Design and development                           of  novel Mycobacterium tuberculosis alanine dehydrogenase inhibitors, Eur. J. Med. Chem.                           2014, 92C, 401-414.
48. R. Srikanth, A. Reshma, K. Pushkar, D. Sriram,P. Yogeeswari, Structure-based drug design,                         synthesis and screening of adenosine A2A antagonists as novel antiepileptic drugs. Epilepsia 2014,                        55, 5. RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL, 2014.

2013

1. A. Seal, P. Yogeeswari, D. Sriram, OSDD Consortium, DJ Wild, Enhanced ranking of PknB inhibitors using data fusion methods. J. Cheminform. 2013, 5, 1-14. (Impact factor: 3.42)
2. V.U. Jean Kumar, O. Poyraz, S. Saxena, R. Schnell, P. Yogeeswari, G. Schneider, D. Sriram, Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening, Bioorg. Med. Chem. Lett. 2013, 23, 1182-1186.
3. M. Mujaheed, R.G. Gonnade,P. Yogeeswari, D. Sriram, M. Muthukrishnan, Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates, Bioorg. Med. Chem. Lett. 2013, 23, 1416-1419. 
4.  R.K. Mishra, A. Reshma, D. Sriram,P. Yogeeswari,Potential Role of Rho Kinase Inhibitors in Combating Diabetes-related Complications including Diabetic Neuropathy- A Review. Curr. Diabetes Rev., 2013, 9, 249-266.
5.  5. P. Ravichand, D. Sriram,P. Yogeeswari,R. Vadrevu, Multiple E-Pharmacophore Modeling combined with High-Throughput Virtual Screening and Docking to Identify Potential Inhibitors of Beta Secretase, Mol. Informatics, 2013, 32, 2-15. Ranked 2nd in the Top ten most accessed articles in 2013 first half.
6. 6.   Yogeeswari,M. Sharma, G. Samala, M. Gangadhar, S. Karthick, S. Mallipeddi, A. Semwal, D. Sriram, Discovery of novel tetrahydropyrazolo [4,3-c] pyridines for the treatment of neuropathic pain: Synthesis and neuropharmacology,Eur. J. Med. Chem., 2013, 66, 211-220. 
7. O. Poyraz, VU Jean Kumar, S. Saxena, R. Schnell, M. Haraldsson,P. Yogeeswari, D. Sriram, G. Schneider, Structure-guided design of novel thiazolidine inhibitors of O-acetylserine sulfhydrylase from Mycobacterium tuberculosis, J. Med. Chem., 2013, 56, 6457-6466.
8. N. Panathur, U. Dalimba, PV Koushik, M. Alvala,P. Yogeeswari, D. Sriram, V. Kumar, Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition, Eur. J. Med. Chem. 2013, 69C, 125-138.
9. T. Yempala, JP Sridevi,P. Yogeeswari, D. Sriram, S. Kantevari, Design, synthesis and antitubercular evaluation of novel 2-substituted-3H-benzofuro benzofurans via palladium-copper catalysed Sonagashira coupling reaction. Bioorg. Med. Chem. Lett. 2013, 23, 5393-5396.
10.  S. Ganesh, P.B. Devi, N. Radhika, P. Yogeeswari, D. Sriram, Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novelMycobacterium tuberculosispantothenate synthestase inhibitors, Eur. J. Med. Chem. 2013, 69, 356-364.
11. V. Hema, P.R. Avula, S.R. Challa, M. Gangadhar,P. Yogeeswari, D. Sriram, Relationship between plasma levels and the anti-neuropathic pain effect of Lamotrigine in rat model, J. Pharm. Res. 2013, 6, 780-784.
12. H.N. Nagesh, K.M. Naidu, D.H. Rao, J.P. Sridevi, D. Sriram,P. Yogeeswari, K.V. Chandrasekhar, Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents. Bioorg. Med. Chem. Lett. 2013, 23, 6805-6810.
13. V.U. Jean Kumar, J. Renuka, P. Santosh, V. Soni, J.P. Sridevi, P. Suryadevara,P. Yogeeswari, D. Sriram, Thiazole aminopiperidine hybrid analogues: Design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors. Eur. J. Med. Chem. 2013, 70, 143-153.
14. T. Yempala, J.P. Sridevi, P. Yogeeswari, D. Sriram, S. Kantevari, Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors ofMycobacterium tuberculosis. Eur. J. Med. Chem. 2013, 71C, 160-167. 
15. J.T. Patrisha, M. Battu, D. Sriram, P. Yogeeswari,3D-QSAR studies combined with virtual screening to identify novel inhibitors of N-acetyl glucosamine-1-phosphate uridyl transferase from Mycobacterium tuberculosis, Int. J. Drug Des. Discov. 2013, 4, 1134-1148.
16. Judge V, Narasimhan B, Ahuja M, Sriram D, Yogeeswari P, De Clercq, E, Pannecouque C, Balzarini J, Synthesis, Antimycobacterial, Antiviral, Antimicrobial Activity and QSAR Studies of N2-acyl Isonicotinic Acid Hydrazide Derivatives, Med. Chem. 2013, 9, 53-76.

 2012

1.        Malwal SR, Sriram D, Yogeeswari P, Konkimalla VB, Chakrapani H. Design, Synthesis, and Evaluation of Thiol-Activated Sources of Sulfur Dioxide (SO(2)) as Antimycobacterial Agents. J. Med. Chem. 2012, 55(1):553-7. Impact factor: 5.207
2. Malwal SR, Sriram D, Yogeeswari P, Chakrapani H. Synthesis and antimycobacterial activity of prodrugs of sulfur             dioxide (SO(2)).  Bioorg. Med. Chem. Lett. 2012, 22, 3603-6.
3.      Yogeeswari P, Sravan Kumar Patel, Ingala Vikram Reddy, Arvind Semwal, Monika Sharma, Gangadhar M,             Siddarth Sai M, Sriram D. GABA derivatives for the treatment of epilepsy and neuropathic pain: A synthetic             integeration of GABA into 1,2,4-Triazol-2H-one nucleus. Biomed. Ageing Pathol. 2012, 2, 31-40.
4.      Ramani AV, Monika A, Lakshmi Indira V, Karyavardhi G, Venkatesh J, Jean Kumar VU, Yogeeswari P, Sriram               D. Synthesis of highly potent anti-tubercular isoniazid analogues with preliminary pharmacokinetic evaluation. Bioorg.    Med. Chem. Lett. 2012, 22, 2764-7.
5.      S.R. Patpi, L. Pulipati, P. Yogeeswari, D. Sriram, N. Jain, B. Sridhar, R. Murthy, S.V. Kalivendhi, S. Kantevari, Design, Synthesis and Structure-Activity Correlations of Novel Dibenzo[b,d]furan, Dibenzo[b,d]thiophene and N-Methylcarbazole Clubbed 1,2,3-Triazoles as Potent Inhibitors of Mycobacterium tuberculosis.  J. Med. Chem.  55, 3911-3922. 
6. A. Mallika, S. Bhatnagar, A. Ravi, V.U. Jean Kumar, T.H. Manjashetty, P. Yogeeswari, D. Sriram, Novel acridinedione derivatives: Design, Synthesis, SIRT1 enzyme and tumour cell growth inhibition studies. Bioorg Med Chem Lett. 2012,22, 3256-60.
7.      D. Sriram, D. Banerjee, T. Sasank, T. V. N. Varuna , M. Sankar,  P.Yogeeswari,  Novel Antitubercular diallyl/dibenzyl thiosemicarbazones endowed with high activity toward multi-drug resistant tuberculosis.   Med. Chem. Res. 2012, 21, 810-815.
8.       Sebastian, A. Desai, P. Yogeeswari, D. Sriram, S.N. Madhusudana, V. Ravi,Combination of N-Methylisatin-β-thiosemicarbazone derivative (SCH-16) with Ribavirin and Mycophenolic acid potentiates the antiviral activity of SCH 16 against Japanese encephalitis virus in vitro. Lett. Appl. Microbiol. 2012, 55, 234-239.
9.       M. Jeyachandran, P. Ramesh, D. Sriram, P. Senthilkumar, P. Yogeeswari, Synthesis and in vitro antitubercular activity of 4-aryl/alkylsulfonylmethylcoumarins as inhibitors of Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett., 2012, 22, 4807-4809.
10.      V.K. Pulla, M.B. Battu, A. Mallika, D. Sriram, P. Yogeeswari, Can targeting SIRT1 to treat type II diabetes be a good stratgy?. A Review.  Expert Opinion on Ther. Targets, 2012, 16, 819-32.
11.      Monika Sharma, Shraddha S. Das, M. Gangadhar, V. Deekshith, D. Sriram, P. Yogeeswari, Novel Piperazinyl Derivatives with Anti-hyperalgesic, anti-allodynic and Anti-inflammatory activities useful in the treatment of Neuropathic Pain, Antiinflammatory and Anti-allergic Agents in Medicinal Chemistry, 2012,  11, 182-190.
12.       Monika Sharma, V. Deekshith, A. Semwal,  D. Sriram, P. Yogeeswari, Discovery of Fused [1,2,4] Triazolo [3,4-b][1,3,4]thiadiazoles as inhibitors of TNF-alpha: Pharmacophore Hybridisation for the Treatment of Neuropathic Pain, Pain and Therapy, 2012, 1, 3.
13.        Yempala T, Sriram D, Yogeeswari P, Kanteveari S,  Molecular hybridization of bioactives: Synthesis and antitubercular evaluation of novel dibenzofuran embodied homoisoflavonoids via Baylis-Hillman reaction, Bioorg. Med. Chem. Lett., 2012, 22, 7426-30.
14.         Jeankumar VU, Chandran M, Samala G, Alvala M, Koushik PV, Yogeeswari P, Salina EG, Sriram D. Development of 5-nitrothiazole derivatives: Identification of leads against both replicative and latent Mycobacterium tuberculosis, Bioorg. Med. Chem. Lett., 2012, 22, 7426-30.
15.         Dharmaraja AT, Alvala M, Sriram D, Yogeeswari P, Chakrapani H, Design, synthesis and evaluation of small molecule reactive oxygen species generators as selective Mycobacterium tuberculosis inhibitors. Chem Commun. (Cambridge), 2012, 48, 10325-7.
16.          Monika S., Garigipati S., Binita K, Deekshith V, Arvind S., Sriram D., Yogeeswari P., Discovery of novel 1,2,4-triazol-5-ones as tumor necrosis factor-alpha inhibitors for the treatment of neuropathic pain. Chem. Biol. Drug Design, 2012, 80, 961-70.
17. Narang, R., Narasimhan, B., Sharma, S., Sriram, D., Yogeeswari, P., De Clercq, E., Pannecouque, C., Balzarini, J. Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of nicotinic acid benzylidene hydrazide derivatives. Med. Chem. Res. 2012, 21, 1557-1576. Impact factor: 1.058

18. Judge, V., Narasimhan, B., Ahuja, M., Sriram, D., Yogeeswari, P., De Clercq, E., Pannecouque, C., Balzarini, J. Synthesis, antimycobacterial, antiviral, antimicrobial activities, and QSAR studies of isonicotinic acid-1-(substituted phenyl)-ethylidene/cycloheptylidene hydrazides.  Med. Chem. Res. 2012, 21, 1935-1952. Impact factor: 1.058

2011

1.  Mugunthan G, Sriram D, Yogeeswari P, Ravindranathan Kartha KP. Synthetic analogues of mycobacterial arabinogalactan linkage-disaccharide part II: synthesis and preliminary screening of lipophilic O-alkyl glycosides. Carbohydr Res. 2011 346: 2401-5. Impact factor: 1.898
2. Chitra, S., Paul, N., Muthusubramanian, S., Manisankar, P., Yogeeswari, P., Sriram, D. A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies. Eur J Med Chem. 2011, 46, 5465-72.  Impact factor: 3.913
3.           Kantevari S, Yempala T, Surineni G, Sridhar B,Yogeeswari P, Sriram D. Synthesis and antitubercular evaluation of novel dibenzo[b,d]furan and 9-methyl-9H-carbazole derived hexahydro-2H-pyrano[3,2-c]quinolines via Povarov reaction. Eur J Med Chem. 2011 46: 4827-33.Impact factor: 3.913
4.  Sriram, D., Yogeeswari, P., Methuku, S., Vyas, D.R.K., Senthilkumar, P., Alvala, M., Jeankumar, V.U. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor. Bioorganic and Medicinal Chemistry Letters 2011 21: 5149-5154. Impact factor: 2.589
5.           Gunasekaran, P., Perumal, S.,Yogeeswari, P., Sriram, D. A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation. Eur. J. Med. Chem. 2011 46:4530-6. Impact factor: 3.913
6. Narasimhan, B., Sharma, D., Kumar, P., Yogeeswari, P., Sriram, D. Synthesis, antimicrobial and antimycobacterial evaluation of [2-(substituted phenyl)-imidazol-1-yl]-pyridin-3-yl-methanones. Journal of Enzyme Inhibition and Medicinal Chemistry 2011 26: 720-727. . Impact factor: 1.574 
7. Narang, R., Narasimhan, B., Sharma, S., Sriram, D., Yogeeswari, P., De Clercq, E., Pannecouque, C., Balzarini, J. Nicotinic acid benzylidene/phenyl-ethylidene hydrazides: Synthesis, antimicrobial evaluation and QSAR studies. Letters in Drug Design & Discovery. 2011 8: 733-749. . Impact factor: 0.668 
8. Rajesh SM, Perumal S, Menéndez JC, Yogeeswari  P, Sriram D. Antimycobacterial activity of spirooxindolo-pyrrolidine, pyrrolizine and pyrrolothiazole hybrids obtained by a three-component regio- and stereoselective 1,3-dipolar cycloaddition. Med. Chem. Commun. 2011 2: 626-30. Top ten most accessed articles in May (Click to find)
9. Yogeeswari P, Menon N, Semwal A, Arjun M, Sriram D. Discovery of molecules for the treatment of neuropathic pain: Synthesis, antiallodynic and antihyperalgesic activities of 5-(4-nitrophenyl)furoic-2-acid hydrazones. Eur J Med Chem. 2011 Jul;46(7):2964-70. Impact factor: 3.913
10. Manjashetty TH, Yogeeswari P, Sriram D. Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues.   Bioorg Med Chem Lett. 2011 Apr 1;21(7):2125-8.  Impact factor: 2.589
11. Rajesh SM, Kumar RS, Libertsen LA, Perumal S, Yogeeswari P, Sriram D. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.  Bioorg Med Chem Lett. 2011 May 15;21(10):3012-6. Impact factor: 2.589
12. Raju BC, Rao RN, Suman P, Yogeeswari P, Sriram D, Shaik TB, Kalivendi SV.  Synthesis, structure-activity relationship of novel substituted 4H-chromen-1,2,3,4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer agents. Bioorg Med Chem Lett. 2011 May 15;21(10):2855-9. Impact factor: 2.589
13. Ranjith Kumar R, Perumal S, Menéndez JC, Yogeeswari P, Sriram D. Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides.  Bioorg Med Chem. 2011 Jun 1;19(11):3444-50. . Impact factor: 3.108
14. Mugunthan G, Ramakrishna K, Sriram D, Yogeeswari P, Ravindranathan Kartha KP. Synthesis and screening of (E)-1-(β-d-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.  Bioorg Med Chem Lett. 2011 Jul 1;21(13):3947-50. Impact factor: 2.589  
15. Raja VP, Perumal S, Yogeeswari P, Sriram D. Synthesis and antimycobacterial activity of highly functionalized tetrahydro-4(1H)-pyridinones. Bioorg Med Chem Lett. 2011 Jul 1;21(13):3881-4. Impact factor: 2.589
16. Mugunthan G, Ramakrishna K, Sriram D, Yogeeswari P, Ravindranathan Kartha KP. Synthesis and screening of galactose-linked nitroimidazoles and triazoles against Mycobacterium tuberculosis. Eur J Med Chem. 2011 46: 4725-4732. Impact factor: 3.913 
17. Kantevari S, Yempala T, Yogeeswari P, Sriram D, Sridhar B. Synthesis and antitubercular evaluation of amidoalkyl dibenzofuranols and 1H-benzo[2,3]benzofuro[4,5-e][1,3]oxazin-3(2H)-ones. Bioorg Med Chem Lett. 2011 Jul 15;21(14):4316-9. Impact factor: 2.589   
18. Kantevari S, Patpi SR, Addla D, Putapatri SR, Sridhar B, Yogeeswari P, Sriram D. Facile Diversity-Oriented Synthesis and Antitubercular Evaluation of Novel Aryl and Heteroaryl Tethered Pyridines and Dihydro-6H-quinolin-5-ones Derived via Variants of the Bohlmann-Rahtz Reaction.  ACS Comb Sci. 2011 Jul 11;13(4):427-35. Impact factor: 3.154  
19. Mugunthan G, Sriram D, Yogeeswari P, Ravindranathan Kartha KP. Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents. Carbohydr Res. 2011 346: 1760-6. Impact factor: 1.898
20. Banerjee D, Yogeeswari P, Bhat P, Thomas A, Srividya M, Sriram D. Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection. Eur J Med Chem. 2010 46: 106-21. Impact factor: 3.913  
21. Kantevari S, Patpi SR, Sridhar B, Yogeeswari P, Sriram D. Synthesis and antitubercular evaluation of novel substituted aryl and thiophenyl tethered dihydro-6H-quinolin-5-ones, Bioorg Med Chem Lett. 2011 21: 1214-7. Impact factor: 2.589 
22.   Shanmugavelan P, Nagarajan S, Sathishkumar M, Ponnuswamy A, Yogeeswari P, Sriram D. Efficient synthesis and in-vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
    Bioorg Med Chem Lett. 2011,21, 7273-7276.
23. Kumar R.R., Perumal S, Menendez JC,Yogeeswari P, Sriram D, Antimycobacterial activity of novel 1,2,4-Oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-diploar cycloadditions of nitrile oxides. Bioorg. Med. Chem. 2011, 19, 3444-3450

2010

27. Yogeeswari P, Reddy A.S.K, Arvind S, Sriram D. Novel role of GABAergic anticonvulsant compounds in alleivating neuropathic pain in two animal models, Ind. J. Pharmacol. 2010 42: 121. Impact factor: 0.303
28. Monika S, Reddy, A.S.K., Arvind S, Sriram D, Yogeeswari P. Effectiveness of newer lipophilic GABA analogues against epilepsy, Ind. J. Pharmacol. 2010 42: 160-161. Impact factor: 0.303
29. Sriram, D., Yogeeswari, P., Senthil Kumar P, Naidu G, Bhat P, 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. J Enzyme Inhib Med Chem. 2010 25, 765-72. Impact factor: 1.574 
30. Kumar P, Narashiman B, Yogeeswari P, Sriram D, Synthesis and antitubercular activities of substituted benzoic acid N'-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)-hydrazides. Eur J Med Chem. 2010 45, 6085-89. Impact factor: 3.193
31. Prasanna P, Balamurugan K, Perumal S, Yogeeswari P, Sriram D, A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of novel spiro-pyrrolothiazolyloxindoles and their antitubercular evaluation. Eur J Med Chem. 2010 45, 5653-61. Impact factor: 3.193
32. Manikannan, R., Venkatesan R, Muthusubramanian, S., Yogeeswari, P., Sriram D. Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity. Bioorg Med Chem Lett. 2010 20: 6920-24. Impact factor: 2.589
33. Maheswari SU, Balamurugan K, Perumal S, Yogeeswari P, Sriram D, A facile 1,3-dipolar cycloaddition of azomethine ylides to 2-arylidene-1,3-indanediones: Synthesis of dispiro-oxindolylpyrrolothiazoles and their antimycobacterial evaluation, Bioorg Med Chem Lett. 2010 20: 7278-82. Impact factor: 2.589
34. Sriram, D., Devakaram, R.V., Dinakaran, M., Yogeeswari, P., Aromatic Amino Analogues of Artemisinin: Synthesis and In-vivo Antimalarial Activity, Med. Chem. Res. 2010 19:524-32. Impact factor: 1.058
35. Kumar, R.S., Mahesh, S.M., Perumal, S., Banerjee, D., Yogeeswari, P., Sriram, D., A facile synthesis and discovery of highly functionalized tetrahydropyridines and pyridines as antimycobacterial agents, Chem. Pharm. Bull. 2010 58:602-10. Impact factor: 1.507
36. Sriram, D., Yogeeswari, P., Vyas, D.R.K., Senthilkumar, P., Bhat, P., Srividya, M., 5-Nitro-2-furoic acid hydrazones: Design, synthesis and in-vitro antimycobacterial evaluation against log and starved phase cultures, Bioorg Med Chem Lett. 2010 20: 4313-6. Impact factor: 2.589
37. Manikannan, R., Muthusubramanian, S., Yogeeswari, P., Sriram D. Selective one-pot multicomponent synthesis and antitubercular evaluation of 5-(aryl/cyclohexylsulphanyl)-2-alkoxy-4,6-diarylnictinonitriles, Bioorg Med Chem Lett. 2010 Jun 1;20(11):3352-5. Impact factor: 2.589
38. Kumar RS, Rajesh SM, Perumal S, Banerjee D, Yogeeswari P, Sriram D. Novel three-component domino reactions of ketones, isatin and amino acids: synthesis and discovery of antimycobacterial activity of highly functionalised novel dispiropyrrolidines., Eur J Med Chem. 2010 Jan;45(1):411-22. Impact factor: 3.193
39. Kumar RS, Perumal S, Shetty KA, Yogeeswari P, Sriram D. 1,3-Dipolar cycloaddition of C-aryl-N-phenylnitrones to (R)-1-(1-phenylethyl)-3-[(E)-arylmethylidene]tetrahydro-4(1H)-pyridinones: synthesis and antimycobacterial evaluation of enantiomerically pure spiroisoxazolidines, Eur J Med Chem. 2010 Jan;45(1):124-33. Impact factor: 3.193
40. Karthikeyan SV, Bala BD, Raja VP, Perumal S, Yogeeswari P, Sriram D., A highly atom economic, chemo-, regio- and stereoselective synthesis and evaluation of spiro-pyrrolothiazoles as antitubercular agents, Bioorg Med Chem Lett. 2010 Jan 1;20(1):350-3. Impact factor: 2.589
41. Sriram D, Yogeeswari P, Dinakaran M, Banerjee D, Bhat P, Gadhwal S., Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives, Eur J Med Chem. 2010 Jan;45(1):120-3. Impact factor: 3.193
42. Balamurugan K, Jeyachandran V, Perumal S, Manjashetty TH, Yogeeswari P, Sriram D., A microwave-assisted, facile, regioselective Friedländer synthesis and antitubercular evaluation of 2,9-diaryl-2,3-dihydrothieno-[3,2-b]quinolines, Eur J Med Chem. 2010 Feb;45(2):682-8. Impact factor: 3.193
43. Sriram D, Yogeeswari P, Senthilkumar P, Sangaraju D, Nelli R, Banerjee D, Bhat P, Manjashetty TH., Synthesis and Antimycobacterial Evaluation of Novel Phthalazin-4-ylacetamides Against log- and Starved Phase Cultures, Chem Biol Drug Des. 2010 Apr; 75(4) 381-91. Impact factor: 2.527
44. Sriram D, Yogeeswari P, Senthilkumar P, Sangaraju D, 5-Nitrothiazolylthiosemicarbazones: synthesis and antimycobacterial evaluation against tubercular and non-tubercular mycobacterial species, J Enzyme Inhibition Med Chem. 2010 Feb;25(1):105-10. Impact factor: 1.574 

2009

45. Yogeeswari P, Semwal A, Mishra R, Sriram D., Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain, Expert Opin Ther Targets. 2009 Aug;13(8):925-43. Impact factor: 3.713
46. Sriram D, Yogeeswari P, Senthilkumar P, Dewakar S, Rohit N, Debjani B, Bhat P, Veugopal B, Pavan VV, Thimmappa HM., Novel pthalazinyl derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis isocitrate lyase enzyme, Med Chem. 2009 Sep;5(5):422-33. Impact factor: 1.603
47. Ranjith Kumar R, Perumal S, Senthilkumar P, Yogeeswari P, Sriram D., A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines, Eur J Med Chem. 2009 Sep;44(9):3821-9. Impact factor: 3.193
48. M. Shalini, P. Yogeeswari, D. Sriram, J.P. Stables, Cyclization of the semicarbazone template of aryl semicarbazones: synthesis and anticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H)-one, Biomed. Pharmacother., 63, 187-193, 2009. Impact factor: 2.198
49. P. Senthilkumar, J. Long, R. Swetha, V. Shruthi, R.R. Wang, S. Preethi, P. Yogeeswari, Y.T. Zheng, D. Sriram, Synthesis of zidovudine derivatives with anti-HIV-1 and antibacterial activities, Nucleosides Nucleotides Nucleic Acids 28:89-102, 2009. Impact factor: 1.132
50. P. Senthilkumar, M. Dinakaran, Y. Chandraseakaran, P. Yogeeswari, D. Sriram D, Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro-8-methyl-6-nitro-4-oxo-7-substituted secondary amino) quinoline-3-carboxylic acids, Arch Pharm (Weinheim) 342:100-12, 2009. . Impact factor: 1.429
51. P. Senthilkumar, M. Dinakaran, P. Yogeeswari, A. China, V. Nagaraja, Antimycobacterial activities of novel fluoroquinolones, Biomed. Pharmacother. 63, 27-35, 2009. Impact factor: 2.198
52. D. Sriram, P. Yogeeswari, P. Dhakla, P. Senthilkumar, D. Banerjee, T.H. Manjashetty, 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species, Bioorg Med Chem Lett. 19:1152-4, 2009. Impact factor: 2.589
53. D. Sriram, D. Banerjee, P. Yogeeswari, Efavirenz Mannich bases: synthesis, anti-HIV and antitubercular activities, J Enzyme Inhib Med Chem. 24:1-5, 2009. . Impact factor: 1.574 
54. P. Senthilkumar, M. Dinakaran, P. Yogeeswari, D. Sriram, A. China, V. Nagaraja, Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids, Eur J Med Chem. 44:345-58, 2009. Impact factor: 3.193
55. D. Sriram, P. Yogeeswari, Y. Priya, Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis, Biomed. Pharmacother. 63, 36-39, 2009. . Impact factor: 2.198
56. M. Dinakaran, P. Senthilkumar, P. Yogeeswari, D. Sriram, Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis, Biomed. Pharmacother. 63, 11-18, 2009. . Impact factor: 2.198
57. Ranjith Kumar R, Perumal S, Manju SC, Bhatt P, Yogeeswari P, Sriram D., An atom economic synthesis and antitubercular evaluation of novel spiro-cyclohexanones, Bioorg Med Chem Lett. 2009 Jul 1;19(13):3461-5. Impact factor: 2.589
58. Karthikeyan SV, Perumal S, Shetty KA, Yogeeswari P, Sriram D., A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles. Bioorg Med Chem Lett. 2009 Jun 1;19(11):3006-9. Impact factor: 2.589

2008

59. P. Yogeeswari, J.V. Ragavendran, D. Sriram, R. Kavya, K. Vanitha, H. Neelakantan. Newer N-phthaloyl GABA derivatives with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain. Pharmacology, 81, 21-31, 2008. Impact factor: 1.802
60. J.V. Ragavendran, D. Sriram, S. Kotapati, J. Stables, P. Yogeeswari. Newer GABA derivatives for the treatment of epilepsy including febrile seizures: A bioisosteric approach. Eur. J. Med. Chem., 43, 2650-5, 2008. Impact factor: 3.193
61. R.R. Kumar, S. Perumal, P. Senthilkumar, P. Yogeeswari, D. Sriram. Discovery of antimycobacterial spiro-piperidin-4-ones: an atom economic, stereoselective synthesis, and biological intervention. J. Med. Chem. 51, 5731-5735, 2008. Impact factor: 5.207
62. M. Dinakaran, P. Senthilkumar, P. Yogeeswari, A. China, V. Nagaraja, D. Sriram. Synthesis, antimycobacterial activities and phototoxic evaluation of 5H-thiazolo[3,2-a]quinoline-4-carboxylic acid derivatives. Med. Chem. 4, 482-491, 2008. Impact factor: 1.603
63. M. Dinakaran, P. Senthilkumar, P. Yogeeswari, A. China, V. Nagaraja, D. Sriram. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation. Bioorg. Med. Chem. Lett., 18, 1229-1236, 2008. Impact factor: 2.589
64. D. Sriram, P. Yogeeswari, M. Dinakaran, M. Sowmya. Synthesis, anti-HIV and antitubercular activities of nelfinavir diester derivatives. Biomed. Pharmacother., 62, 1-5, 2008. . Impact factor: 2.198
65. P. Senthilkumar, M. Dinakaran, D. Banerjee, R.V. Devakaram, P. Yogeeswari, A. China, V. Nagaraja, D. Sriram. Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids. Bioorg. Med. Chem., 16, 2558-2569, 2008. . Impact factor: 3.108
66. M. Dinakaran, P. Senthilkumar, P. Yogeeswari, A. China, V. Nagaraja, D. Sriram. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid. Bioorg Med Chem., 16, 3408-3418, 2008. Impact factor: 3.108
67. M. Dinakaran, P. Senthilkumar, P. Yogeeswari, A. China, V. Nagaraja, D. Sriram. Antimycobacterial and phototoxic evaluation of novel 6-fluoro/nitro-4-oxo-7-(sub)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid. Int. J. Antimicrob. Agents., 31, 337-344, 2008. Impact factor: 3.787
68. L. Sebastian, A. Desai, M.N. Shampur, P. Yogeeswari, D. Sriram, Vasanthapuram R. N-Methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo. Virol. J., 5:64, 2008. Impact factor: 2.55

2007

69. P. Yogeeswari, J. Vaigunda Ragavendran, D. Sriram, Y. Nageswari, R. Kavya, N. Sreevatsan, K. Vanitha, J. Stables. Discovery of 4-Aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: A Hybrid pharmacophore approach. J. Med. Chem., 50, 2459-2467, 2007. Impact factor: 5.207
70. J.V. Ragavendran, I. Vikram Reddy, P. Yogeeswari, D. Sriram. Synthesis of 4-{[(3Z)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]amino}-N-substituted phenyl) butanamides possessing antiallodynic and antihyperalgersic activities in two rat models of neuropathic pain. Med. Chem. Res., 15, 225-226, 2007. Impact factor: 1.058
71. J. V. Ragavendran, D. Sriram, S.K. Patel, I. Vikram Reddy, N. Bharathwajan, J. Stables, P. Yogeeswari. Design and Synthesis of Anticonvulsants from a Combined Phthalimide-GABA –Anilide and Hydrazone Pharmacophore. Eur. J. Med. Chem., 42, 146-151, 2007. Impact factor: 3.193
72. P. Yogeeswari, J.V. Ragavendran, D. Sriram. Neuropathic pain: Strategies in drug discovery and treatment. Expert Opinion on Drug Discovery, 2, 169-184, 2007.
73. P. Yogeeswari, D. Sriram, P. Sahitya, J.V. Ragavendran, V. Ranganadh.Synthesis and anticonvulsant activity of 4-(2-(2,6-dimethylphenylamino)-2-oxoethylamino)-N-(substituted)butanamides: A Pharmacophoric hybrid approach. Bioorg. Med. Chem. Lett., 17, 3712-3715, 2007. Impact factor: 2.589
74. A.S.K. Reddy, J.V. Ragavendran, P. Yogeeswari, D. Sriram. Pharmacological screening of candidate anticonvulsants in the animal model of febrile seizures. Med. Chem. Res., 15, 285-286, 2007. Impact factor: 1.058
75. D. Sriram, P. Senthilkumar, M. Dinakaran, P. Yogeeswari, A. China, V. Nagaraja. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid. J. Med. Chem., 50, 6232-6239, 2007. Impact factor: 5.207
76. S. Mehta, P. Yogeeswari, Roheeth Kumar, D. Sriram. Heteroaryl-substituted semicarbazones: Synthesis and anticonvulsant activity of N-(3-Methylpyridin-2-yl)-substituted semicarbazones. J. Het. Chem., 43, 1287-1293, 2007. Impact factor: 0.962
77. D. Sriram, P. Yogeeswari, M. Dinakaran, R. Thirumurugan. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea endowed with high activity toward multi-drug resistant tuberculosis. J. Antimicrob. Chemother. 59, 1194-1196, 2007. Impact factor: 4.659
78. R.R. Kumar, S. Perumal, P. Senthilkumar,  P. Yogeeswari, D. Sriram. An atom efficient, solvent-free, green synthesis and antimycobacterial evaluation of 2-amino-6-methyl-4-aryl-8-[(E)-arylmethylidene]-5,6,7,8-tetrahydro-4H-pyrano[3,2-c]pyridine-3-carbonitriles. Bioorg. Med. Chem. Lett. 17, 6459-6462, 2007. Impact factor: 2.589
79. P. Senthil Kumar, M. Dinakaran, P. Yogeeswari, D. Sriram. Synthesis and antitubercular activities of 1-(cyclopropyl/t-butyl/4-fluorophenyl)-1,4-dihydro-6-nitro-4-oxo-7-(substituted secondary amines)-1,8-naphthyridine-3-carboxylic acid. Med. Chem. Res., 15, 281-282, 2007. Impact factor: 1.058
80. D. Sriram, P. Yogeeswari, Prathiba Dakhla, P. Senthil Kumar, Debjani Banerjee. N-Hydroxythiosemicarbazones: Synthesis and in-vitro antitubercular activity. Bioorg. Med. Chem. Lett., 17, 1888-1893, 2007. Impact factor: 2.589
81. D. Banerjee, T.R. Bal, P. Yogeeswari, D. Sriram, L. Sebastin, A. Desai, S.N. Madhusudhana, V. Ravi. Isatin derivatives as inhibitor of Japanese encephalitis virus entry and replication in-vitro. Med. Chem. Res., 15, 133-135, 2007. Impact factor: 1.058
82. Shalini, P. Yogeeswari, D. Sriram, S. Induja. Microwave-assisted Synthesis, Anticonvulsant activity and Quantum Mechanical modeling of N-(4-Bromo-3-methylphenyl)semicarbazones. J. Zhejiang Univ. Section B (Springer), 8, 45-55, 2007. Impact factor: 1.679
83. K.N. Purna, P. Dhakla, P. Senthil Kumar, P. Yogeeswari, D. Sriram. 5-Nitro-2-furaldehyde thiosemicarbazones: Synthesis and in-vitro antimycobacterial activities. Med. Chem. Res., 15, 223-224, 2007. Impact factor: 1.058
84. M. Dinakaran, C. Yogesh, P. Yogeeswari, D. Sriram  Synthesis of various 7-substituted-1-t-butyl-1,4-dihydro-8-methyl-6-nitro-4-oxo quiniline-3-carboxylic acid. Med. Chem. Res., 15, 328, 2007. Impact factor: 1.058
85. D. Sriram, P. Yogeeswari, G. Senchani, D. Banerjee. Newer Tetracycline derivatives: Synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase. Bioorg. Med. Chem. Lett.,17, 2372-2375, 2007. Impact factor: 5.207
86. D. Sriram, P. Yogeeswari, N. Raveendra Babu, K.N. Purna. Synthesis and in-vitro anti-HIV activities of Didanosine prodrugs. J. Enzyme Inhib., 22, 51-55, 2007. Impact factor: 1.574 
87. M.A. Ali, M.S. Yar, A.A. Siddiqui, D. Sriram, P. Yogeeswari, E. De Clercq. Synthesis and anti-HIV activity of N'-nicotinoyl--3-(4'-hydroxy-3'-methylphenyl)-5-[substituted phenyl]-2-pyrazolines. Acta. Pol. Pharm., 64, 423-428, 2007. Impact factor: 0.35 
88. J.V. Ragavendran, P. Roheeth Kumar, P. Yogeeswari, Design of GABA uptake inhibitors: synthesis and anticonvulsant properties, Neurol. Asia, 12, 113-114, 2007.

2006

89. D. Sriram, P. Yogeeswari, M.R. Kishore Synthesis and anti-HIV activity of nevirapine prodrugs. Pharmazie., 61, 895-897, 2006. Impact factor: 0.869
90. M.S. Yar, M.A. Ali, D. Sriram, P. Yogeeswari. Synthesis and antimicrobial activity of 3-(4'-hydroxy-3'-methylphenyl)-5-[(substuted) phenyl]-4,5-dihydro-1H-1-pyrazolyl-4-pyridylmethanone derivatives. Acta. Pol. Pharm., 63, 491-496, 2006. Impact factor: 0.35 
91. M. Shalini, P. Yogeeswari, D. Sriram, P. Kudyar, P.R. Kumar, S. Induja, J.P. Stables Quantum mechanical modeling of N4-(2, 5-disubstituted phenyl) semicarbazones: synthesis and anticonvulsant activity of N4-(2, 5-dimethylphenyl/ -2-fluoro-5-methyl phenyl) semicarbazones. Med. Chem., 2, 617-625,  2006. Impact factor: 1.603
92. D. Sriram, P. Yogeeswari, R. Thirumurugan, P. Roheeth Kumar. Discovery of Newer Antitubercular Oxazolyl thiosemicarbazones. J. Med. Chem. 49, 3448-3450, 2006. Impact factor: 5.207
93. D. Sriram, P. Yogeeswari, K. Madhu. Synthesis and in-vitro antitubercular activity of some 1-[(4-sub)phenyl]- 3-(4-{1-   [(pyridine-4-carbonyl)hydrazono]ethyl phenyl) thiourea. Bioorg. Med. Chem. Lett. 16, 876-878, 2006. Impact factor: 2.589
94. D. Sriram, P. Yogeeswari, R.V. Devakaram. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Bioorg. Med. Chem., 14, 3113-3118, 2006. Impact factor: 3.108
95. D. Sriram, P. Yogeeswari, S.P. Reddy Synthesis of Pyrazinamide Mannich bases and its antitubercular properties. Bioorg. Med. Chem. Lett., 16, 2113-2116, 2006. Impact factor: 2.589
96. D. Sriram, A. Aubry, P. Yogeeswari, L.M. Fischer. Gatifloxacin derivatives: Synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase. Bioorg. Med. Chem. Lett., 16, 2982-2985, 2006. Impact factor: 2.589
97. D. Sriram, P. Yogeeswari, K. Meena. Design, synthesis, anti-HIV and antitubercular activities of isatin derivatives. Pharmazie, 61, 271-274, 2006. Impact factor: 0.869
98. P. Yogeeswari, D. Sriram, J. Vaigunda Raghavendran, R. Thirumurugan, S. Induja, J.P. Stables. Synthesis and structure-activity relationship on anticonvulsant aryl semicarbazones. Med. Chem., 2, 55-62, 2006. Impact factor: 1.603
99. P. Yogeeswari, D. Sriram, R. Thirumurugan, J.P. Stables 2,4-Dimethoxyphenyl semicarbazones with anticonvulsant activity against three animal models of seizure: Synthesis and Pharmacological evaluation Bioorg. Med. Chem., 14, 3106-3112, 2006. Impact factor: 3.108
100. P. Yogeeswari, D. Sriram, R.Thirumurugan, T. R. Bal Epibatidine and its analogues as nicotinic acetylcholine receptor agonist. An update. Nat. Prod. Res., 20, 497-505, 2006. Impact factor: 0.906
101. P. Yogeeswari, R.Thirumurugan, D. Sriram,  L.R.J. Suniljit, J. Vaigunda Ragavendran, R. Kavya, K. Rakhra, J.P. Stables. Synthesis of some new semicarbazone derivatives as anticonvulsants with GABA- mediated mechanism. Acta. Pharm., 56, 259-272, 2006. Impact factor: 0.453
102. M. Shaharyar, A.A. Siddiqui, M. Asharaf Ali, D. Sriram, P. Yogeeswari. Synthesis and in-vitro antimycobacterial activity of N¹-Nicotinoyl-3-(4’-hydroxy-3’-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines. Bioorg. Med. Chem. Lett., 16, 3947-3949, 2006. Impact factor: 2.589
103. D. Sriram, P. Yogeeswari, N.S. Myneedu, V. Saraswat. Abacavir prodrugs: Microwave-assisted synthesis and their evaluation of anti-HIV activities. Bioorg. Med. Chem. Lett., 16, 2127-2129, 2006. Impact factor: 2.589
104. D. Sriram, T. R. Bal, P. Yogeeswari, D.R. Radha, V. Nagaraja. Evaluation of antimycobacterial and DNA gyrase inhibition of fluoroquinolone derivatives. J. Gen. App. Microbiol., 52, 195-200, 2006. Impact factor: 0.960
105. P. Yogeeswari, J.V. Ragavendran, D. Sriram. An Update on GABA Analogs for CNS Drug Discovery. Recent Patent on CNS Drug Discov.,  Vol 1 (First issue) 113-118, 2006.

2005

106. P. Yogeeswari, D. Sriram, J.V. Raghavendran, R. Thirumurugan. The GABA shunt: An attractive and potential therapeutic target in the treatment of epileptic disorders. Curr. Drug Metabolism, 6, 127-140, 2005. Impact factor: 3.896
107. P. Yogeeswari, D. Sriram, R. Thirumurugan, J.V. Raghavendran, K. Sudhan, Roheeth Kumar, J. Stables. Discovery of N-(2,6-Dimethylphenyl) substituted Semicarbazones as Anticonvulsants : Hybrid Pharmacophore-based design J. Med. Chem., 48, 6202-6211, 2005. Impact factor: 5.207
108. D. Sriram, T. R. Bal, P. Yogeeswari. Aminopyrimidinimino isatin analogues: Design and synthesis of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum anti-microbial properties Med. Chem., 1, 277-285, 2005. Impact factor: 1.603
109. D. Sriram, T. R. Bal, P. Yogeeswari. Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: Design, synthesis and biological evaluation. Farmaco, 60, 377-384, 2005. Impact factor: 0.79
110. D. Sriram, P.Yogeeswari, A.N. Nagappa. Combinatorial Synthesis of anti-HIV-1 agents. Comb. Chem. High Throughput Screen., 8(6), 377-385, 2005. Impact factor: 2.573
111. D. Sriram, P. Yogeeswari, R.Thirumurugan, T. R. Bal. Camptothecin and its analogues: A review on their chemotherapeutic potential. Nat. Prod. Res., 19, 393-412, 2005. Impact factor: 0.906
112. P.Yogeeswari, D. Sriram, V.Veena, R.Kavya, K.Rakhra, S.Mehta, J.VaigundaRagavendran, R.Thirumurugan, J.P.Stables. Synthesis of Novel Aryl semicarbazones as Potential Anticonvulsant Agents. Biomed. Pharmacother., 59, 51-55, 2005. . Impact factor: 2.198
113. P. Yogeeswari, D. Sriram, S. Mehta, D. Nigam, M. Mohan Kumar, S. Murugesan, J.P. Stables. Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones. Farmaco, 60 (1), 1-5, 2005. Impact factor: 0.79
114. P. Yogeeswari and D. Sriram Betulinic acid and its derivatives: A review on their biological properties. Curr. Med. Chem., 12 (3), 763-771, 2005. Impact factor: 4.63
115. D. Sriram, P. Yogeeswari, J.S. Basha, D. R. Radha, V. Nagaraja. Synthesis and Antimycobacterial evaluation of various 7- Substituted Ciprofloxacin Derivatives Bioorg. Med. Chem., 13, 5774-5778, 2005. Impact factor: 3.108
116. D. Sriram, P. Yogeewari and K. Madhu. Synthesis and in-vitro antimycobacterial activity of some isonicotinyl hydrazones. Bioorg. Med. Chem. Lett., 15, 4502-4505, 2005. Impact factor: 2.589
117. T.R. Bal, B. Anand, P. Yogeeswari, D. Sriram. Synthesis and evaluation of anti-HIV activity of isatin b-thiosemicarbazone derivatives. Bioorg. Med. Chem. Lett., 15, 4451-4455, 2005. Impact factor: 2.589
118. D. Sriram, P. Yogeeswari, T.G. Ashok Kumar Microwave-assisted synthesis, and anti-YFV activity of 2, 3-diaryl-1, 3-thiazolidin-4-ones J. Pharm. Pharm. Sci., 8, 429-466, 2005. Impact factor: 0.38
119. D. Sriram, P. Yogeeswari, N. Srichakravarthy, T. R. Bal. Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. Biomed. Pharmacother. 59, 452-455, 2005. Impact factor: 2.198
120. D. Sriram, P. Yogeeswari, N. Srichakravarthy, T. R. Bal. Nevirapine derivatives with broad spectrum chemotherapeutic properties for the effective treatment of HIV / AIDS. Biomed. Pharmacother., 59, 456-459, 2005. Impact factor: 2.198
121. D. Sriram, P. Yogeeswari, T.G. Ashok Kumar. Microwave-assisted synthesis, anti-HIV activity of 2, 3-diaryl-1, 3-thiazolidin-4-ones. Ind. J. Pharm. Sci., 67, 496-499, 2005. Impact factor: 0.455
122. D. Sriram, P. Yogeeswari, T.G. Ashok Kumar. Microwave Assisted Synthesis, Anti-HIV, and Anti-YFV Activities of Schiff Bases of N-Hydroxy-N¹-Aminoguanidine tosylate. Ind. J. Pharm. Sci., 67, 493-496, 2005. Impact factor: 0.455
123. D. Sriram, T. R. Bal, P. Yogeeswari. Aminopyrimidinimino isatin analogues: Design of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties. J. Pharm. Pharm. Sci., 8, 565-577, 2005. Impact factor: 0.38
124. P. Yogeeswari, D. Sriram, R. Kavya, S. Tiwari. Synthesis and in-vitro cytotoxicity evaluation of gatifloxacin Mannich bases. Biomed. Pharmacother.,  59, 501-510, 2005. Impact factor: 2.198
125. D. Sriram, P. Yogeeswari, Gayatri Gopal. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. Eur. J. Med. Chem., 40, 1373-1376, 2005. Impact factor: 3.193
126. D. Sriram, T. R. Bal, P. Yogeeswari. Design, synthesis and biological evaluation of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum antimicrobial properties: Aminopyrimidinimino isatin analogues. Med. Chem. Res., 14, 211-228, 2005. Impact factor: 1.058

2003-2004

127. D. Sriram, V. S. Rao, K. V. G. Chandrasekhar andP. Yogeeswari. Progress in the research of artemisinin and its analogues as anti-malarials: an update Nat. Prod. Res., 18(6), 503-527, 2004. Impact factor: 0.906
128. D. Sriram, T. R. Bal, P. Yogeeswari. Design, synthesis and biological evaluation of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties. Bioorg. Med. Chem., 12, 5865-5873, 2004. . Impact factor: 3.108
129. P. Yogeeswari, J. Vaigunda Raghavendran, R. Thirumurugan, A. Saxena. D. Sriram. Ion channels as important targets for antiepileptic drug design. Curr. Drug Targets, 5, 589-602, 2004. . Impact factor: 3.061
130. D. Sriram, P. Yogeeswari, R. Thirumurugan. Antituberculous activity of some aryl semicarbazones derivatives. Bioorg. Med. Chem. Lett., 15, 3923-3924, 2004. . Impact factor: 2.589
131. P. Yogeeswari, D. Sriram, S.N. Pandeya, J.P. Stables. 4-Sulphamoylphenyl semicarbazones with anticonvulsant activity. Farmaco, 59, 609-613, 2004. Impact factor: 0.79
132. P. Yogeeswari, R. Thirumurugan, R. Kavya, J. Selwyn Samuel, J.P. Stables, D. Sriram. 2-Methyl, 3-chlorophenyl-substituted semicarbazones: Synthesis and anticonvulsant activity. Eur. J. Med. Chem., 39, 729-734, 2004. (Impact factor: 3.193
133. D. Sriram, P. Yogeeeswari, N. Srichakravarthy, Tanushree Ratan Bal. Synthesis of Stavudine Amino acid Ester Prodrugs with Broad-Spectrum Chemotherapeutic Properties for the Effective Treatment of HIV/AIDS. Bioorg. Med. Chem. Lett., 14, 1085-1087, 2004. Impact factor: 2.589
134. P. Yogeeswari, D. Sriram, A.Brahmandam, I.Sridharan, R.Thirumurugan and J.P. Stables. Synthesis of novel aryl semicarbazones as anticonvulsants with GABA-mediated mechanism. Med. Chem. Res., 12(2), 57-68, 2003 Impact factor: 1.058
135. P. Yogeeswari, D. Sriram, V.Saraswat, J.Vaigunda Ragavendran, M.Mohan Kumar, S.Murugesan, R.Thirumurugan, J.P.Stables. Synthesis and Anticonvulsant and Neurotoxicity Evaluation of N⁴ –Phthalimido Phenyl (Thio) Semicarbazides. Eur. J. Pharm. Sci., 20, 341-346, 2003. Impact factor: 3.291
136. D. Sriram, P. Yogeeswari. Towards the Design and Development of Agents with Broad Spectrum Chemotherapeutic Properties for the Effective Treatment of HIV / AIDS. Curr. Med. Chem., 10, 1909-1915, 2003. Impact factor: 4.63

2001-2002

137. S.N. Pandeya, P. Yogeeswari, D. Sriram, G.Nath. Antibacterial and antifungal activities of N-Mannich bases of 3-[N²-pyrimethaminylimino] isatin. Ind. J. Pharm. Sci., 64, 209-212, 2002. Impact factor: 0.455
138. P. Yogeeswari, D. Sriram, L.R.J. Suniljit, S.S.Kumar, J.P.Stables. Anticonvulsant and neurotoxicity evaluation of some 6-chlorobenzothiazolyl-2-thiosemicarbazones. Eur. J. Med. Chem., 37, 231-236, 2002.Impact factor: 3.193
139. S.N. Pandeya,P. Yogeeswari, E.A.Sausville, A.B.Mauger, V.L.Narayanan, Synthesis and antitumour evaluation of 4-bromophenyl semicarbazones, Arzneim. Forschung/ Drug Res., 52, 103-108, 2002. Impact factor: 0.632
140. S.N. Pandeya, D. Sriram,P.Yogeeswari, S. Ananthan. Antituberculous activity of Norfloxacin Mannich bases with Isatin derivatives. Chemotherapy, 47, 266-269, 2001. Impact factor: 2.03
141. S.N.Pandeya, D. Sriram, P. Yogeeswari, J.P. Stables. Anticonvulsant and Neurotoxicity evaluation of 5-(un)-substituted isatinimino derivatives. Pharmazie, 56, 875-878, 2001. Impact factor: 0.869

1998-2000

142. S.N.Pandeya,P. Yogeeswari, J.P. Stables, Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones, Eur. J. Med. Chem., 35, 879-886, 2000. Impact factor: 3.193
143. S.N. Pandeya, P. Yogeeswari, D. Sriram, E. De Clercq, C. Pannecouque, M. Witvrouw. Synthesis and Screening for Anti-HIV activity of some N-Mannich bases of isatin derivatives. Chemotherapy, 45, 192-196, 1999. Impact factor: 2.03
144. S.N. Pandeya,P. Yogeeswari, D. Sriram, G.Nath. Synthesis and antimicrobial activity of N-Mannich bases of 3-[N’-sulphadoximino] Isatin and its methyl derivative. Boll. Chim. Farm. 137(8), 321-324, 1998.Impact Factor: 1.35